Safety and efficacy of laparoscopic radical gastrectomy after neoadjuvant chemotherapy plus immunotherapy: a retrospective cohort study
NACI significantly improved pCR rates and R0 resection rates in patients with LAGC without increasing perioperative risk, but did not translate into short-term survival benefits.
Authors
- Fei He (ORCID: https://orcid.org/0000-0002-1165-3248)
- Kai Zhong (ORCID: https://orcid.org/0000-0003-2472-513X)
- Chenglin Tang (ORCID: https://orcid.org/0009-0004-7151-3564)
- Yu Zou (ORCID: https://orcid.org/0000-0001-5699-5869)
- Yunlong Zhang (ORCID: https://orcid.org/0000-0003-1684-5748)
- Kun Qian (ORCID: https://orcid.org/0000-0001-8626-3976)
- Juan Xiong (ORCID: https://orcid.org/0000-0002-0209-0332)
Institutions
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-09-04
- DOI
- https://doi.org/10.3389/fimmu.2025.1672547
- Citations
- 1
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.52